Abstract
We have treated 17 patients with non-A, non-B chronic hepatitis by recombinant interferon alpha (0.3–9 megaunits for 4–28 weeks). In six patients, serum aminotransferase levels fell to normal or near-normal range during treatment. The mean levels of serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in 17 patients fell from 156±80 (mean±sd) and 213±135 at the beginning of treatment to 94±49 and 112±71, respectively, at the end of treatment. In 12 patients, liver biopsies were performed before and after (or during) the treatment, and histological activity indices (HAI) were blindly examined by two independent observers. For comparison, we examined histological changes of pre- and posttreatment liver biopsies of 19 patients who were treated by recombinant interferon for chronic hepatitis B. Mean HAI scores improved from 10.0 to 5.4 after treatment in non-A, non-B chronic hepatitis. The most marked reduction was noted in scores of portal inflammation and hepatocellular degeneration and/or necrosis. No such reduction was observed in B- viral chronic hepatitis. These data indicated that rapid biochemical resolution by the treatment was related to histological improvement of the liver in our patients with non-A, non-B hepatitis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Yokosuka O, Omata M, Imazeki F, Ito Y, Okuda K: Hepatitis B virus RNA transcripts and DNA in chronic liver disease. N Engl J Med 315:1187–1192, 1986
Omata M, Aschcavai M, Liew CT, Peters RL: Hepatocellular carcinoma in the USA, etiologic consideration. Localization of hepatitis B antigens. Gastroenterology 76:279–287, 1979
Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Bisceglie AD, Peters M, Waggoner JG, Park Y, Jones EA: Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. N Engl J Med 315:1575–1578, 1986
Bianchi L, De Groote J, Desmet VJ, Gedigk P, Korb G, Popper H, Poulsen H, Schever PJ, Schmid M, Thaler H, Wepler W: Acute and chronic hepatitis revisited. Review by an international group. Lancet 2:914–919, 1977
Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J: Formulation and application to a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431–435, 1981
Omata M, Imazeki F, Yokosuka O, Ito Y, Uchiumi K, Mori J, Okuda K: Recombinant leukocyte A interferon treatment in patients with chronic hepatitis B virus infection. Pharmakokinetics, tolerance, and biologic effects. Gastroenterology 88:870–880, 1985
Yokosuka O, Omata M, Imazeki F, Okuda K, Summers J: Changes of hepatitis B virus DNA in liver and serum caused by recombinant leukocyte interferon treatment: Analysis of intrahepatic replicative hepatitis B virus DNA. Hepatology 5:728–734, 1985
Thomson BJ, Doran M, Lever AML, Webster ADB: Alphainterferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy. Lancet 1:539–541, 1987
Berman M, Alter HJ, Ishak KG, Purcell RH, Jones EA: The chronic sequelae of non-A, non-B hepatitis. Ann Intern Med 91:1–6, 1979
Rakela J, Redeker AG: Chronic liver disease after acute non-A, non-B viral hepatitis. Gastroenterology 72:902–909, 1977
Knodell RG, Conrad ME, Ishak KG: Development of chronic liver disease after non-A, non-B post-transfusion hepatitis. Gastroenterology 72:902–909, 1977
Omata M, Iwama S, Sumida M, Ito Y, Okuda K: Clinicopathological study of acute non-A, non-B post transfusion hepatitis: histological features of liver biopsies in acute phase. Liver 1:201–208, 1981
Author information
Authors and Affiliations
Additional information
This work was supported in part by grants from Ministry of Health and Welfare, and Ministry of Education, Science and Culture (Japan).
Rights and permissions
About this article
Cite this article
Omata, M., Ito, Y., Yokosuka, O. et al. Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Digest Dis Sci 34, 330–337 (1989). https://doi.org/10.1007/BF01536251
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01536251